CervoMed Inc (CRVO)

Currency in USD
8.0500
-0.2000(-2.42%)
Closed·
After Hours
8.05000.0000(0.00%)
·
CRVO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CRVO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.81008.2500
52 wk Range
1.800020.6300
Key Statistics
Prev. Close
8.25
Open
8.25
Day's Range
7.81-8.25
52 wk Range
1.8-20.63
Volume
72.48K
Average Volume (3m)
202.49K
1-Year Change
-45.79%
Book Value / Share
3.98
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CRVO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.8333
Upside
+96.69%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period

CervoMed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

CervoMed Inc Company Profile

CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in DLB and certain other major neurological disorders. It is being evaluated in a Phase 2b study in patients with DLB. The company develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Compare CRVO to Peers and Sector

Metrics to compare
CRVO
Peers
Sector
Relationship
P/E Ratio
−3.8x−0.6x−0.5x
PEG Ratio
0.03−0.100.00
Price/Book
2.0x0.7x2.6x
Price / LTM Sales
7.5x0.4x3.2x
Upside (Analyst Target)
81.8%−11.8%40.5%
Fair Value Upside
Unlock26.0%4.4%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.8333
(+96.69% Upside)

Earnings

Latest Release
May 12, 2025
EPS / Forecast
-0.56 / -0.59
Revenue / Forecast
1.92M / --
EPS Revisions
Last 90 days

CRVO Income Statement

People Also Watch

271.20
AVAV
-0.59%
2.78
INMB
-2.80%
14.20
OSCR
-10.52%
709.26
AXON
+0.57%
26.76
CNC
-9.04%

FAQ

What Stock Exchange Does CervoMed Trade On?

CervoMed is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for CervoMed?

The stock symbol for CervoMed is "CRVO."

What Is the CervoMed Market Cap?

As of today, CervoMed market cap is 69.62M.

What Is CervoMed's Earnings Per Share (TTM)?

The CervoMed EPS (TTM) is -2.14.

From a Technical Analysis Perspective, Is CRVO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has CervoMed Stock Split?

CervoMed has split 5 times.

How Many Employees Does CervoMed Have?

CervoMed has 15 employees.

What is the current trading status of CervoMed (CRVO)?

As of 25 Jul 2025, CervoMed (CRVO) is trading at a price of 8.05, with a previous close of 8.25. The stock has fluctuated within a day range of 7.81 to 8.25, while its 52-week range spans from 1.80 to 20.63.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.